AI drug companies are expensive to build, and some of the early clinical readouts have underwhelmed investors.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
Generative AI Finds Its Footing in Drug Development
Pictured: Robot hand holding microscope, pill bottles and DNA/Taylor Tieden for BioSpace Xaira Therapeutics launched April 23 with $1 billion behind it to apply artificial intelligence to drug discovery and development. It was the largest […]
News
Innovative Multi-Modality Whole Body Red Light Therapy Bed Launched
TheraLight launches the new TheraLight 360i model featuring exclusive Intelligent Integration of Light, Sound, and PEMF LINDON, Utah, May 20, 2025 /PRNewswire/ — TheraLight, LLC, a leader in whole-body Photobiomodulation, proudly announces the launch of […]
News
Covr Acquires Data IQ to Expand Analytics Capabilities of its Workforce Management Platform
The merger combines Covr’s expertise in workforce management with Data IQ’s powerful data capabilities to create a unified platform for skilled nursing facilities to drive better performance. LINDON, Utah, Jan. 28, 2025 /PRNewswire/ — Covr, […]
